State of Illinois
2021 and 2022


Introduced 1/5/2022, by Rep. Robyn Gabel


New Act
720 ILCS 570/102  from Ch. 56 1/2, par. 1102

    Creates the Naturopathic Medical Practice Act. Provides for the licensure of naturopathic physicians. Creates the Naturopathic Physician Medical Board. Provides that the Board shall oversee the licensure of naturopathic physicians and matters relating to training and licensure of naturopathic physicians. Provides for membership of the Board and duties of the Board. Requires the Board to adopt rules concerning specified matters. Contains provisions concerning definitions; qualifications for licensure; approval of naturopathic medical educational programs; display of license; scope of practice; referral requirements; prohibited conduct by licensees; exemptions from the Act; title protection; license expiration, renewal, denial, revocation, and continuing education; and issuance of first licenses. Amends the Illinois Controlled Substances Act. Adds internal references to naturopathic physicians. Effective immediately.

LRB102 21704 SPS 30823 b






HB4294LRB102 21704 SPS 30823 b

1    AN ACT concerning regulation.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 1. Short title. This Act may be cited as the
5Naturopathic Medical Practice Act.
6    Section 5. Purpose and findings. The practice of
7naturopathic medicine in the State of Illinois is declared to
8affect the public health, safety, and welfare and to be
9subject to regulation and control in the public interest. It
10is further declared to be a matter of public interest that
11naturopathic physicians and the practice of naturopathic
12medicine, as defined in this Act, merit the confidence of the
13public, that only qualified persons be authorized to practice
14naturopathic medicine in the State of Illinois, and that no
15person shall practice naturopathic medicine without a valid
16existing license to do so.
17    Illinois is facing an unprecedented physician shortage in
18urban counties and an even higher shortage in rural counties.
19The COVID-19 pandemic is increasing that shortage
20exponentially. Naturopathic physicians with a proper scope of
21practice can help fill this void.
22    The General Assembly recognizes that naturopathic
23physicians comprise a distinct health care profession that



HB4294- 2 -LRB102 21704 SPS 30823 b

1affects the public health, safety, and welfare and that
2licensure of naturopathic physicians will increase freedom of
3choice in health care and help address the physician shortage
4in Illinois. This Act shall be liberally construed to best
5carry out these subjects and purposes.
6    Section 10. Definitions. In this Act:
7    "Approved naturopathic medical educational program" means
8an educational program that the Board has approved as meeting
9the requirements of Section 20 of this Act that prepares
10naturopathic physicians for the practice of naturopathic
12    "Association" means an entity that is approved by the
13American Association of Naturopathic Physicians, which entity
14represents the interests of naturopathic physicians in this
16    "Board" means the Naturopathic Physician Medical Board
17established pursuant to Section 55 of this Act.
18    "Clinical laboratory procedure" means the use of
19venipuncture consistent with naturopathic medical practice,
20commonly used diagnostic modalities consistent with
21naturopathic practice, the recording of a patient's health
22history, physical examination, ordering and interpretation of
23radiographic diagnostics and other standard imaging and
24examination of body orifices, excluding endoscopy and
25colonoscopy. "Clinical laboratory procedure" includes the



HB4294- 3 -LRB102 21704 SPS 30823 b

1practice of obtaining samples of human tissues, except
2surgical excision beyond surgical excision that is authorized
3as a minor office procedure.
4    "Drug" has the same meaning as set forth in Section 102 of
5the Illinois Controlled Substances Act.
6    "Homeopathic medicine" means a system of medicine based on
7the use of infinitesimal doses of substances capable of
8producing symptoms similar to those of the disease treated, as
9listed in the Homeopathic Pharmacopoeia of the United States.
10    "Hygiene" means the use of preventive techniques,
11including personal hygiene for asepsis, public health, and
13    "Laboratory examination" means:
14        (1) phlebotomy;
15        (2) a clinical laboratory procedure;
16        (3) an orificial examination;
17        (4) a physiological function test; and
18        (5) a screening or test that is consistent with
19    naturopathic education and training.
20    "Legend drug" has the same meaning as set forth in Section
213.23 of the Illinois Food, Drug and Cosmetic Act.
22    "License" means a license issued by the Board to an
23individual pursuant to this Act and rules authorizing that
24individual to practice naturopathic medicine in this State.
25    "Licensee" means a naturopathic physician licensed by the
26Board to practice naturopathic medicine in this State.



HB4294- 4 -LRB102 21704 SPS 30823 b

1    "Minor office procedure" means minor surgical care and
2procedures, including:
3        (1) surgical care incidental to superficial
4    laceration, lesion, or abrasion, excluding surgical care
5    to treat a lesion suspected of malignancy;
6        (2) the removal of foreign bodies located in
7    superficial structures, excluding the globe of the eye;
8        (3) trigger point therapy;
9        (4) dermal stimulation;
10        (5) allergy testing and treatment; and
11        (6) the use of antiseptics and topical or local
12    anesthetics.
13    "Naturopathic medicine" means:
14        (1) a system of health care for the prevention,
15    diagnosis and treatment of human health conditions,
16    injury, and disease;
17        (2) the promotion or restoration of health; and
18        (3) the support and stimulation of a patient's
19    inherent self-healing processes through patient education
20    and the use of naturopathic therapies and therapeutic
21    substances.
22    "Naturopathic physical medicine" means the use of one or
23more of the following physical agents in a manner consistent
24with naturopathic medical practice on a part or the whole of
25the body, by hand or by mechanical means, in the resolution of
26a human ailment or conditions:



HB4294- 5 -LRB102 21704 SPS 30823 b

1        (1) air;
2        (2) water;
3        (3) heat;
4        (4) cold;
5        (5) sound;
6        (6) light;
7        (7) electromagnetism;
8        (8) colon hydrotherapy;
9        (9) soft tissue therapy;
10        (10) joint mobilization;
11        (11) therapeutic exercise; or
12        (12) naturopathic manipulation.
13    "Naturopathic physician" means an individual licensed
14pursuant to this Act as a naturopathic physician to practice
15naturopathic medicine in this State.
16    "Naturopathic therapy" means the use of:
17        (1) naturopathic physical medicine;
18        (2) suggestion;
19        (3) hygiene;
20        (4) a therapeutic substance;
21        (5) nutrition and food science;
22        (6) homeopathic medicine;
23        (7) a clinical laboratory procedure; or
24        (8) a minor office procedure.
25    "Nutrition and food science" means the prevention and
26treatment of disease or other human conditions through the use



HB4294- 6 -LRB102 21704 SPS 30823 b

1of food, water, herbs, roots, bark, or natural food elements.
2    "Prescription" has the same meaning as set forth in
3Section 3 of the Pharmacy Practice Act.
4    "Professional examination" means a competency based
5national naturopathic physician licensing examination
6administered by the North American Board of Naturopathic
7Examiners or its successor agency, which Board has been
8nationally recognized to administer a naturopathic examination
9that represents federal standards of education and training.
10    "Suggestion" means a technique using:
11        (1) biofeedback;
12        (2) hypnosis;
13        (3) health education; or
14        (4) health counseling.
15    "Therapeutic substance" means any of the following
16exemplified in a standard naturopathic medical text, journal,
17or pharmacopeia:
18        (1) a vitamin;
19        (2) a mineral;
20        (3) a nutraceutical;
21        (4) a botanical medicine;
22        (5) oxygen;
23        (6) a homeopathic medicine;
24        (7) a hormone;
25        (8) a hormonal or pharmaceutical contraceptive device;
26    or



HB4294- 7 -LRB102 21704 SPS 30823 b

1        (9) other physiologic substance.
2    Section 15. Qualifications for licensure. The Board shall
3license an applicant who:
4        (1) submits, in accordance with rules of the Board,
5    the following items to the Board:
6            (A) an application for licensure designed and
7        approved by the Board and submitted in accordance with
8        rules of the Board;
9            (B) an application fee submitted in an amount and
10        manner established by rules of the Board;
11            (C) evidence that the applicant has graduated from
12        an approved naturopathic medical educational program;
13            (D) evidence that the applicant has passed a
14        professional examination;
15            (E) evidence that the applicant has passed a
16        pharmacy examination authorized by rules of the Board
17        and administered by the North American Board of
18        Naturopathic Examiners or its successor;
19            (F) evidence that the applicant has passed a minor
20        surgery examination authorized by rules of the Board
21        and administered by the North American Board of
22        Naturopathic Examiners or its successor; and
23            (G) evidence of professional liability insurance
24        with policy limits not less than prescribed by the
25        Board;



HB4294- 8 -LRB102 21704 SPS 30823 b

1        (2) is determined by the Board to be physically and
2    mentally capable of safely practicing naturopathic
3    medicine with or without reasonable accommodation; and
4        (3) has not had a license to practice naturopathic
5    medicine or other health care license, registration, or
6    certificate refused, revoked, or suspended by any other
7    jurisdiction for reasons that relate to the applicant's
8    ability to skillfully and safely practice naturopathic
9    medicine unless that license, registration, or
10    certification has been restored to good standing by that
11    jurisdiction.
12    Section 20. Approved naturopathic medical educational
13program. The Board shall establish, by rule, guidelines for an
14approved naturopathic medical educational program, which
15guidelines shall meet the following requirements and the
16Board's specifications for the education of naturopathic
17physicians. The approved naturopathic medical educational
18program shall:
19        (1) offer graduate-level, full-time didactic and
20    supervised clinical training;
21        (2) be accredited, or have achieved candidacy status
22    for accreditation, by the Council on Naturopathic Medical
23    Education or an equivalent federally recognized
24    accrediting body for naturopathic medical programs that is
25    also recognized by the Board; and



HB4294- 9 -LRB102 21704 SPS 30823 b

1        (3) be conducted by an institution of higher
2    education, or a division of an institution of higher
3    education, that:
4            (A) is accredited or is a candidate for
5        accreditation by a regional or national institutional
6        accrediting agency recognized by the United States
7        Secretary of Education or a diploma-granting,
8        degree-equivalent college or university; or
9            (B) meets equivalent standards for recognition of
10        accreditation established by rules of the Board for
11        medical education programs offered in Canada.
12    Section 25. Display of license. A licensee shall display
13the licensee's license in the licensee's place of business in
14a location clearly visible to the licensee's patients and
15shall also display evidence of the licensee having completed
16an approved naturopathic medical educational program.
17    Section 30. Scope of practice. A licensee may practice
18naturopathic medicine to provide primary care in alignment
19with naturopathic medical education to:
20        (1) perform physical examinations;
21        (2) order laboratory examinations;
22        (3) order diagnostic imaging studies;
23        (4) interpret the results of laboratory examinations
24    for diagnostic purposes;



HB4294- 10 -LRB102 21704 SPS 30823 b

1        (5) order and, based on a radiologist's report, take
2    action on diagnostic imaging studies in a manner
3    consistent with naturopathic training;
4        (6) prescribe, administer, dispense, and order food,
5    extracts of food, nutraceuticals, vitamins, amino acids,
6    minerals, enzymes, botanicals and their extracts,
7    botanical medicines, homeopathic medicines, dietary
8    supplements, and nonprescription drugs as defined by the
9    Federal Food, Drug, and Cosmetic Act;
10        (7) prescribe, administer, dispense, and order all
11    legend drugs and all drugs within Schedules II-V of the
12    Controlled Substances Act;
13        (8) administer intramuscular, intravenous,
14    subcutaneous, intra-articular and intradermal injections
15    of substances appropriate to naturopathic medicine;
16        (9) use routes of administration that include oral,
17    nasal, auricular, ocular, rectal, vaginal, transdermal,
18    intradermal, subcutaneous, intravenous, intra-articular,
19    and intramuscular consistent with the education and
20    training of a naturopathic physician;
21        (10) perform naturopathic physical medicine;
22        (11) employ the use of naturopathic therapy;
23        (12) use therapeutic devices, barrier contraception,
24    intrauterine devices, hormonal and pharmaceutical
25    contraception, and durable medical equipment;
26        (13) administer vaccinations upon completion of



HB4294- 11 -LRB102 21704 SPS 30823 b

1    appropriate training set forth by rule and approved by the
2    Department on appropriate vaccine storage, proper
3    administration, and addressing contraindications and
4    adverse reactions; and
5        (14) perform minor office procedures.
6    Section 35. Referral requirement. A licensee shall refer
7to a physician licensed to practice medicine in all of its
8branches under the Medical Practice Act of 1987 any patient
9whose medical condition is determined, at the time of
10evaluation or treatment, to be beyond the scope of practice of
11the licensee.
12    Section 40. Prohibitions. A licensee shall not:
13        (1) perform surgery outside of the scope of minor
14    office procedures permitted in the employment of
15    naturopathic therapy;
16        (2) use general or spinal anesthetics;
17        (3) administer ionizing radioactive substances for
18    therapeutic purposes;
19        (4) perform a surgical procedure using a laser device;
20        (5) perform a surgical procedure involving any of the
21    following areas of the body that extend beyond superficial
22    tissue:
23            (A) eyes;
24            (B) ears;



HB4294- 12 -LRB102 21704 SPS 30823 b

1            (C) tendons;
2            (D) nerves;
3            (E) veins; or
4            (F) arteries;
5        (6) perform a surgical abortion;
6        (7) treat any lesion suspected of malignancy or
7    requiring surgical removal; or
8        (8) perform acupuncture.
9    Section 45. Exemptions. Nothing in this Act shall be
10construed to prohibit or to restrict:
11        (1) the practice of a health care profession by an
12    individual who is licensed, certified, or registered under
13    other laws of this State and who is performing services
14    within the individual's authorized scope of practice;
15        (2) the practice of naturopathic medicine by a student
16    enrolled in an approved naturopathic medical educational
17    program if the practice of naturopathic medicine by a
18    student is performed pursuant to a course of instruction
19    or an assignment from an instructor at an accredited
20    university or college by an instructor duly licensed as a
21    health care provider in Illinois;
22        (3) any person that sells a vitamin or herb from
23    providing information about the vitamin or herb;
24        (4) the practice of naturopathic medicine by persons
25    who are licensed to practice in any other state or



HB4294- 13 -LRB102 21704 SPS 30823 b

1    district in the United States and who enter this State to
2    consult with a naturopathic physician of this State if the
3    consultation is limited to examination, recommendation, or
4    testimony in litigation; or
5        (5) any person or practitioner who is not licensed as
6    a naturopathic physician from recommending ayurvedic
7    medicine, herbal remedies, nutritional advice, homeopathy,
8    or other therapy that is within the scope of practice of
9    naturopathic medicine; however, the person or practitioner
10    shall not:
11            (A) use a title protected pursuant to Section 50
12        of this Act;
13            (B) represent or assume the character or
14        appearance of a licensee; or
15            (C) otherwise use a name, title, or other
16        designation that indicates or implies that the person
17        is a licensee.
18    Section 50. Protected titles.
19    (a) A licensee shall use the title "naturopathic
20physician", "naturopathic doctor", or "naturopathic medical
21doctor" and the recognized abbreviations "N.D." and "N.M.D.".
22    (b) A licensee has the exclusive right to use the
23following terms in reference to the licensee's self:
24        (1) "naturopathic physician";
25        (2) "naturopathic doctor";



HB4294- 14 -LRB102 21704 SPS 30823 b

1        (3) "naturopathic medical doctor";
2        (4) "doctor of naturopathic medicine";
3        (5) "doctor of naturopathy";
4        (6) "naturopath";
5        (7) "N.D.";
6        (8) "ND";
7        (9) "NMD"; and
8        (10) "N.M.D.".
9    (c) An individual represents the individual's self to be a
10naturopathic physician or a naturopathic doctor when the
11individual uses or adopts any of the following terms in
12reference to the individual's self:
13        (1) "naturopathic physician";
14        (2) "naturopathic doctor";
15        (3) "naturopathic medical doctor";
16        (4) "doctor of naturopathic medicine";
17        (5) "doctor of naturopathy";
18        (6) "naturopath";
19        (7) "N.D.";
20        (8) "ND";
21        (9) "NMD"; and
22        (10) "N.M.D.".
23    (d) An individual shall not represent the individual's
24self to the public as a naturopathic physician, naturopathic
25doctor, naturopathic medical doctor, a doctor of naturopathic
26medicine, a doctor of naturopathy, or as being otherwise



HB4294- 15 -LRB102 21704 SPS 30823 b

1authorized to practice naturopathic medicine in this State,
2unless the individual is a licensee.
3    Section 55. Naturopathic Physician Medical Board.
4    (a) The Naturopathic Physician Medical Board shall
6        (1) licensure of naturopathic physicians; and
7        (2) matters relating to training and licensure of
8    naturopathic physicians.
9    (b) Within 90 days after the effective date of this Act,
10the Governor shall appoint an initial Board consisting of 2
11members for terms of 4 years each, 3 members for terms of 3
12years each, and 4 members for terms of 2 years each. The
13initial Board shall consist of 9 voting members as follows:
14        (1) five licensed naturopathic physicians who are
15    residents of Illinois and are members of the Illinois
16    Association of Naturopathic Physicians;
17        (2) two practicing physicians licensed to practice
18    medicine in all of its branches with experience working
19    with naturopathic physicians; and
20        (3) two public members that are residents of this
21    State who are not, and never have been, a licensed health
22    care practitioner and who do not have an interest in
23    naturopathic education, naturopathic medicine, or
24    naturopathic business or practice.
25    (c) As the terms of the initial Board members expire, the



HB4294- 16 -LRB102 21704 SPS 30823 b

1Governor shall appoint successors for terms of 4 years each as
3        (1) five naturopathic physicians licensed pursuant to
4    this Act;
5        (2) two practicing physicians licensed to practice
6    medicine in all of its branches with experience working
7    with naturopathic physicians; and
8        (3) two public members that are residents of this
9    State who are not, and never have been, a licensed health
10    care practitioner and who do not have an interest in
11    naturopathic education, naturopathic medicine or
12    naturopathic business or practice.
13    (d) Within 30 days after the Board is established, the
14Board shall call the first meeting, at which meeting members
15shall elect a chair. At least once during each calendar
16quarter thereafter, the Board shall hold a meeting at the call
17of the chair. The Board may hold additional meetings at the
18call of the chair or at the written request of any 2 members of
19the Board.
20    (e) Vacancies on the Board shall be filled from a list of
21not fewer than 3 candidates provided by the Illinois
22Association of Naturopathic Physicians.
23    (f) A majority of the Board membership shall constitute a
25    (g) Members of the Board shall serve without compensation
26but may, at the discretion of the Board, be reimbursed for



HB4294- 17 -LRB102 21704 SPS 30823 b

1their expenses incurred in performing their duties.
2    (h) The Department of Financial and Professional
3Regulation shall provide administrative and other support to
4the Board.
5    Section 60. Board duties. The Board shall adopt rules:
6        (1) regulating the licensure of naturopathic
7    physicians and determining the hours of continuing
8    education units required for maintaining licensure as a
9    naturopathic physician;
10        (2) prescribing the manner in which records of
11    examinations and treatments shall be kept and maintained;
12        (3) establishing standards for professional
13    responsibility and conduct;
14        (4) identifying disciplinary actions and circumstances
15    that require disciplinary action;
16        (5) developing a means to provide information to all
17    licensees in this State;
18        (6) providing for the investigation of complaints
19    against licensees or persons holding themselves out as
20    naturopathic physicians in this State;
21        (7) providing for the publication of information for
22    the public about licensees and the practice of
23    naturopathic medicine in this State;
24        (8) providing for an orderly process for reinstatement
25    of a license;



HB4294- 18 -LRB102 21704 SPS 30823 b

1        (9) establishing criteria for advertising or
2    promotional materials;
3        (10) establishing continuing education hours and
4    content;
5        (11) establishing procedures and standards for
6    reviewing licensing examination scores; and
7        (12) establishing procedures for reviewing transcripts
8    demonstrating completion of the approved naturopathic
9    medical educational program;
10        (13) establishing and maintaining a list of
11    naturopathic medical education programs that meet the
12    requirements of Section 20;
13        (14) establishing the requirements for issuance and
14    renewal of licenses; and
15        (15) any other matter necessary to implement this Act.
16    Section 65. License expiration, renewal, denial,
17revocation, and continuing education.
18    (a) A license issued or renewed pursuant to this Act shall
19expire in a time frame determined by the Board.
20    (b) The Board may renew the license of any licensee who,
21upon the expiration of the licensee's license:
22        (1) has submitted an application for renewal;
23        (2) has paid the renewal fee established by rules of
24    the Board;
25        (3) meets the qualifications for licensure set forth



HB4294- 19 -LRB102 21704 SPS 30823 b

1    in this Act and rules of the Board; and
2        (4) meets the continuing education requirements
3    established by the Board.
4    (c) If the Board intends to refuse to issue or renew,
5revoke, or suspend a license, the Board shall grant the
6applicant or licensee an opportunity for a hearing.
7    Section 70. Issuance of first licenses. On a schedule
8determined by the Board, the Board shall issue licenses to
9those applicants who have met the requirements of this Act and
10Board rules adopted in accordance with this Act.
11    Section 100. The Illinois Controlled Substances Act is
12amended by changing Section 102 as follows:
13    (720 ILCS 570/102)  (from Ch. 56 1/2, par. 1102)
14    Sec. 102. Definitions. As used in this Act, unless the
15context otherwise requires:
16    (a) "Addict" means any person who habitually uses any
17drug, chemical, substance or dangerous drug other than alcohol
18so as to endanger the public morals, health, safety or welfare
19or who is so far addicted to the use of a dangerous drug or
20controlled substance other than alcohol as to have lost the
21power of self control with reference to his or her addiction.
22    (b) "Administer" means the direct application of a
23controlled substance, whether by injection, inhalation,



HB4294- 20 -LRB102 21704 SPS 30823 b

1ingestion, or any other means, to the body of a patient,
2research subject, or animal (as defined by the Humane
3Euthanasia in Animal Shelters Act) by:
4        (1) a practitioner (or, in his or her presence, by his
5    or her authorized agent),
6        (2) the patient or research subject pursuant to an
7    order, or
8        (3) a euthanasia technician as defined by the Humane
9    Euthanasia in Animal Shelters Act.
10    (c) "Agent" means an authorized person who acts on behalf
11of or at the direction of a manufacturer, distributor,
12dispenser, prescriber, or practitioner. It does not include a
13common or contract carrier, public warehouseman or employee of
14the carrier or warehouseman.
15    (c-1) "Anabolic Steroids" means any drug or hormonal
16substance, chemically and pharmacologically related to
17testosterone (other than estrogens, progestins,
18corticosteroids, and dehydroepiandrosterone), and includes:
19    (i) 3[beta],17-dihydroxy-5a-androstane, 
20    (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, 
21    (iii) 5[alpha]-androstan-3,17-dione, 
22    (iv) 1-androstenediol (3[beta], 
23        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
24    (v) 1-androstenediol (3[alpha], 
25        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
26    (vi) 4-androstenediol  



HB4294- 21 -LRB102 21704 SPS 30823 b

1        (3[beta],17[beta]-dihydroxy-androst-4-ene), 
2    (vii) 5-androstenediol  
3        (3[beta],17[beta]-dihydroxy-androst-5-ene), 
4    (viii) 1-androstenedione  
5        ([5alpha]-androst-1-en-3,17-dione), 
6    (ix) 4-androstenedione  
7        (androst-4-en-3,17-dione), 
8    (x) 5-androstenedione  
9        (androst-5-en-3,17-dione), 
10    (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- 
11        hydroxyandrost-4-en-3-one), 
12    (xii) boldenone (17[beta]-hydroxyandrost- 
13        1,4,-diene-3-one), 
14    (xiii) boldione (androsta-1,4- 
15        diene-3,17-dione), 
16    (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 
17        [beta]-hydroxyandrost-4-en-3-one), 
18    (xv) clostebol (4-chloro-17[beta]- 
19        hydroxyandrost-4-en-3-one), 
20    (xvi) dehydrochloromethyltestosterone (4-chloro- 
21        17[beta]-hydroxy-17[alpha]-methyl- 
22        androst-1,4-dien-3-one), 
23    (xvii) desoxymethyltestosterone 
24    (17[alpha]-methyl-5[alpha] 
25        -androst-2-en-17[beta]-ol)(a.k.a., madol), 
26    (xviii) [delta]1-dihydrotestosterone (a.k.a.  



HB4294- 22 -LRB102 21704 SPS 30823 b

1        '1-testosterone') (17[beta]-hydroxy- 
2        5[alpha]-androst-1-en-3-one), 
3    (xix) 4-dihydrotestosterone (17[beta]-hydroxy- 
4        androstan-3-one), 
5    (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- 
6        5[alpha]-androstan-3-one), 
7    (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- 
8        hydroxyestr-4-ene), 
9    (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- 
10        1[beta],17[beta]-dihydroxyandrost-4-en-3-one), 
11    (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], 
12        17[beta]-dihydroxyandrost-1,4-dien-3-one), 
13    (xxiv) furazabol (17[alpha]-methyl-17[beta]- 
14        hydroxyandrostano[2,3-c]-furazan), 
15    (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one, 
16    (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- 
17        androst-4-en-3-one), 
18    (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- 
19        dihydroxy-estr-4-en-3-one), 
20    (xxviii) mestanolone (17[alpha]-methyl-17[beta]- 
21        hydroxy-5-androstan-3-one), 
22    (xxix) mesterolone (1amethyl-17[beta]-hydroxy- 
23        [5a]-androstan-3-one), 
24    (xxx) methandienone (17[alpha]-methyl-17[beta]- 
25        hydroxyandrost-1,4-dien-3-one), 
26    (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- 



HB4294- 23 -LRB102 21704 SPS 30823 b

1        dihydroxyandrost-5-ene), 
2    (xxxii) methenolone (1-methyl-17[beta]-hydroxy- 
3        5[alpha]-androst-1-en-3-one), 
4    (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- 
5        dihydroxy-5a-androstane, 
6    (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy 
7        -5a-androstane, 
8    (xxxv) 17[alpha]-methyl-3[beta],17[beta]- 
9        dihydroxyandrost-4-ene), 
10    (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- 
11        methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), 
12    (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- 
13        hydroxyestra-4,9(10)-dien-3-one), 
14    (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- 
15        hydroxyestra-4,9-11-trien-3-one), 
16    (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- 
17        hydroxyandrost-4-en-3-one), 
18    (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- 
19        hydroxyestr-4-en-3-one), 
20    (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone  
21        (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- 
22        androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- 
23        1-testosterone'), 
24    (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), 
25    (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- 
26        dihydroxyestr-4-ene), 



HB4294- 24 -LRB102 21704 SPS 30823 b

1    (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- 
2        dihydroxyestr-4-ene), 
3    (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- 
4        dihydroxyestr-5-ene), 
5    (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- 
6        dihydroxyestr-5-ene), 
7    (xlvii) 19-nor-4,9(10)-androstadienedione  
8        (estra-4,9(10)-diene-3,17-dione), 
9    (xlviii) 19-nor-4-androstenedione (estr-4- 
10        en-3,17-dione), 
11    (xlix) 19-nor-5-androstenedione (estr-5- 
12        en-3,17-dione), 
13    (l) norbolethone (13[beta], 17a-diethyl-17[beta]- 
14        hydroxygon-4-en-3-one), 
15    (li) norclostebol (4-chloro-17[beta]- 
16        hydroxyestr-4-en-3-one), 
17    (lii) norethandrolone (17[alpha]-ethyl-17[beta]- 
18        hydroxyestr-4-en-3-one), 
19    (liii) normethandrolone (17[alpha]-methyl-17[beta]- 
20        hydroxyestr-4-en-3-one), 
21    (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- 
22        2-oxa-5[alpha]-androstan-3-one), 
23    (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- 
24        dihydroxyandrost-4-en-3-one), 
25    (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- 
26        17[beta]-hydroxy-(5[alpha]-androstan-3-one), 



HB4294- 25 -LRB102 21704 SPS 30823 b

1    (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- 
2        (5[alpha]-androst-2-eno[3,2-c]-pyrazole), 
3    (lviii) stenbolone (17[beta]-hydroxy-2-methyl- 
4        (5[alpha]-androst-1-en-3-one), 
5    (lix) testolactone (13-hydroxy-3-oxo-13,17- 
6        secoandrosta-1,4-dien-17-oic 
7        acid lactone), 
8    (lx) testosterone (17[beta]-hydroxyandrost- 
9        4-en-3-one), 
10    (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- 
11        diethyl-17[beta]-hydroxygon- 
12        4,9,11-trien-3-one), 
13    (lxii) trenbolone (17[beta]-hydroxyestr-4,9, 
14        11-trien-3-one). 
15    Any person who is otherwise lawfully in possession of an
16anabolic steroid, or who otherwise lawfully manufactures,
17distributes, dispenses, delivers, or possesses with intent to
18deliver an anabolic steroid, which anabolic steroid is
19expressly intended for and lawfully allowed to be administered
20through implants to livestock or other nonhuman species, and
21which is approved by the Secretary of Health and Human
22Services for such administration, and which the person intends
23to administer or have administered through such implants,
24shall not be considered to be in unauthorized possession or to
25unlawfully manufacture, distribute, dispense, deliver, or
26possess with intent to deliver such anabolic steroid for



HB4294- 26 -LRB102 21704 SPS 30823 b

1purposes of this Act.
2    (d) "Administration" means the Drug Enforcement
3Administration, United States Department of Justice, or its
4successor agency.
5    (d-5) "Clinical Director, Prescription Monitoring Program"
6means a Department of Human Services administrative employee
7licensed to either prescribe or dispense controlled substances
8who shall run the clinical aspects of the Department of Human
9Services Prescription Monitoring Program and its Prescription
10Information Library.
11    (d-10) "Compounding" means the preparation and mixing of
12components, excluding flavorings, (1) as the result of a
13prescriber's prescription drug order or initiative based on
14the prescriber-patient-pharmacist relationship in the course
15of professional practice or (2) for the purpose of, or
16incident to, research, teaching, or chemical analysis and not
17for sale or dispensing. "Compounding" includes the preparation
18of drugs or devices in anticipation of receiving prescription
19drug orders based on routine, regularly observed dispensing
20patterns. Commercially available products may be compounded
21for dispensing to individual patients only if both of the
22following conditions are met: (i) the commercial product is
23not reasonably available from normal distribution channels in
24a timely manner to meet the patient's needs and (ii) the
25prescribing practitioner has requested that the drug be



HB4294- 27 -LRB102 21704 SPS 30823 b

1    (e) "Control" means to add a drug or other substance, or
2immediate precursor, to a Schedule whether by transfer from
3another Schedule or otherwise.
4    (f) "Controlled Substance" means (i) a drug, substance,
5immediate precursor, or synthetic drug in the Schedules of
6Article II of this Act or (ii) a drug or other substance, or
7immediate precursor, designated as a controlled substance by
8the Department through administrative rule. The term does not
9include distilled spirits, wine, malt beverages, or tobacco,
10as those terms are defined or used in the Liquor Control Act of
111934 and the Tobacco Products Tax Act of 1995.
12    (f-5) "Controlled substance analog" means a substance:
13        (1) the chemical structure of which is substantially
14    similar to the chemical structure of a controlled
15    substance in Schedule I or II;
16        (2) which has a stimulant, depressant, or
17    hallucinogenic effect on the central nervous system that
18    is substantially similar to or greater than the stimulant,
19    depressant, or hallucinogenic effect on the central
20    nervous system of a controlled substance in Schedule I or
21    II; or
22        (3) with respect to a particular person, which such
23    person represents or intends to have a stimulant,
24    depressant, or hallucinogenic effect on the central
25    nervous system that is substantially similar to or greater
26    than the stimulant, depressant, or hallucinogenic effect



HB4294- 28 -LRB102 21704 SPS 30823 b

1    on the central nervous system of a controlled substance in
2    Schedule I or II.
3    (g) "Counterfeit substance" means a controlled substance,
4which, or the container or labeling of which, without
5authorization bears the trademark, trade name, or other
6identifying mark, imprint, number or device, or any likeness
7thereof, of a manufacturer, distributor, or dispenser other
8than the person who in fact manufactured, distributed, or
9dispensed the substance.
10    (h) "Deliver" or "delivery" means the actual, constructive
11or attempted transfer of possession of a controlled substance,
12with or without consideration, whether or not there is an
13agency relationship. "Deliver" or "delivery" does not include
14the donation of drugs to the extent permitted under the
15Illinois Drug Reuse Opportunity Program Act.
16    (i) "Department" means the Illinois Department of Human
17Services (as successor to the Department of Alcoholism and
18Substance Abuse) or its successor agency.
19    (j) (Blank).
20    (k) "Department of Corrections" means the Department of
21Corrections of the State of Illinois or its successor agency.
22    (l) "Department of Financial and Professional Regulation"
23means the Department of Financial and Professional Regulation
24of the State of Illinois or its successor agency.
25    (m) "Depressant" means any drug that (i) causes an overall
26depression of central nervous system functions, (ii) causes



HB4294- 29 -LRB102 21704 SPS 30823 b

1impaired consciousness and awareness, and (iii) can be
2habit-forming or lead to a substance abuse problem, including,
3but not limited to, alcohol, cannabis and its active
4principles and their analogs, benzodiazepines and their
5analogs, barbiturates and their analogs, opioids (natural and
6synthetic) and their analogs, and chloral hydrate and similar
7sedative hypnotics.
8    (n) (Blank).
9    (o) "Director" means the Director of the Illinois State
10Police or his or her designated agents.
11    (p) "Dispense" means to deliver a controlled substance to
12an ultimate user or research subject by or pursuant to the
13lawful order of a prescriber, including the prescribing,
14administering, packaging, labeling, or compounding necessary
15to prepare the substance for that delivery.
16    (q) "Dispenser" means a practitioner who dispenses.
17    (r) "Distribute" means to deliver, other than by
18administering or dispensing, a controlled substance.
19    (s) "Distributor" means a person who distributes.
20    (t) "Drug" means (1) substances recognized as drugs in the
21official United States Pharmacopoeia, Official Homeopathic
22Pharmacopoeia of the United States, or official National
23Formulary, or any supplement to any of them; (2) substances
24intended for use in diagnosis, cure, mitigation, treatment, or
25prevention of disease in man or animals; (3) substances (other
26than food) intended to affect the structure of any function of



HB4294- 30 -LRB102 21704 SPS 30823 b

1the body of man or animals and (4) substances intended for use
2as a component of any article specified in clause (1), (2), or
3(3) of this subsection. It does not include devices or their
4components, parts, or accessories.
5    (t-3) "Electronic health record" or "EHR" means an
6electronic record of health-related information on an
7individual that is created, gathered, managed, and consulted
8by authorized health care clinicians and staff.
9    (t-3.5) "Electronic health record system" or "EHR system"
10means any computer-based system or combination of federally
11certified Health IT Modules (defined at 42 CFR 170.102 or its
12successor) used as a repository for electronic health records
13and accessed or updated by a prescriber or authorized
14surrogate in the ordinary course of his or her medical
15practice. For purposes of connecting to the Prescription
16Information Library maintained by the Bureau of Pharmacy and
17Clinical Support Systems or its successor, an EHR system may
18connect to the Prescription Information Library directly or
19through all or part of a computer program or system that is a
20federally certified Health IT Module maintained by a third
21party and used by the EHR system to secure access to the
23    (t-4) "Emergency medical services personnel" has the
24meaning ascribed to it in the Emergency Medical Services (EMS)
25Systems Act.
26    (t-5) "Euthanasia agency" means an entity certified by the



HB4294- 31 -LRB102 21704 SPS 30823 b

1Department of Financial and Professional Regulation for the
2purpose of animal euthanasia that holds an animal control
3facility license or animal shelter license under the Animal
4Welfare Act. A euthanasia agency is authorized to purchase,
5store, possess, and utilize Schedule II nonnarcotic and
6Schedule III nonnarcotic drugs for the sole purpose of animal
8    (t-10) "Euthanasia drugs" means Schedule II or Schedule
9III substances (nonnarcotic controlled substances) that are
10used by a euthanasia agency for the purpose of animal
12    (u) "Good faith" means the prescribing or dispensing of a
13controlled substance by a practitioner in the regular course
14of professional treatment to or for any person who is under his
15or her treatment for a pathology or condition other than that
16individual's physical or psychological dependence upon or
17addiction to a controlled substance, except as provided
18herein: and application of the term to a pharmacist shall mean
19the dispensing of a controlled substance pursuant to the
20prescriber's order which in the professional judgment of the
21pharmacist is lawful. The pharmacist shall be guided by
22accepted professional standards, including, but not limited
23to, the following, in making the judgment:
24        (1) lack of consistency of prescriber-patient
25    relationship,
26        (2) frequency of prescriptions for same drug by one



HB4294- 32 -LRB102 21704 SPS 30823 b

1    prescriber for large numbers of patients,
2        (3) quantities beyond those normally prescribed,
3        (4) unusual dosages (recognizing that there may be
4    clinical circumstances where more or less than the usual
5    dose may be used legitimately),
6        (5) unusual geographic distances between patient,
7    pharmacist and prescriber,
8        (6) consistent prescribing of habit-forming drugs.
9    (u-0.5) "Hallucinogen" means a drug that causes markedly
10altered sensory perception leading to hallucinations of any
12    (u-1) "Home infusion services" means services provided by
13a pharmacy in compounding solutions for direct administration
14to a patient in a private residence, long-term care facility,
15or hospice setting by means of parenteral, intravenous,
16intramuscular, subcutaneous, or intraspinal infusion.
17    (u-5) "Illinois State Police" means the Illinois State
18Police or its successor agency.
19    (v) "Immediate precursor" means a substance:
20        (1) which the Department has found to be and by rule
21    designated as being a principal compound used, or produced
22    primarily for use, in the manufacture of a controlled
23    substance;
24        (2) which is an immediate chemical intermediary used
25    or likely to be used in the manufacture of such controlled
26    substance; and



HB4294- 33 -LRB102 21704 SPS 30823 b

1        (3) the control of which is necessary to prevent,
2    curtail or limit the manufacture of such controlled
3    substance.
4    (w) "Instructional activities" means the acts of teaching,
5educating or instructing by practitioners using controlled
6substances within educational facilities approved by the State
7Board of Education or its successor agency.
8    (x) "Local authorities" means a duly organized State,
9County or Municipal peace unit or police force.
10    (y) "Look-alike substance" means a substance, other than a
11controlled substance which (1) by overall dosage unit
12appearance, including shape, color, size, markings or lack
13thereof, taste, consistency, or any other identifying physical
14characteristic of the substance, would lead a reasonable
15person to believe that the substance is a controlled
16substance, or (2) is expressly or impliedly represented to be
17a controlled substance or is distributed under circumstances
18which would lead a reasonable person to believe that the
19substance is a controlled substance. For the purpose of
20determining whether the representations made or the
21circumstances of the distribution would lead a reasonable
22person to believe the substance to be a controlled substance
23under this clause (2) of subsection (y), the court or other
24authority may consider the following factors in addition to
25any other factor that may be relevant:
26        (a) statements made by the owner or person in control



HB4294- 34 -LRB102 21704 SPS 30823 b

1    of the substance concerning its nature, use or effect;
2        (b) statements made to the buyer or recipient that the
3    substance may be resold for profit;
4        (c) whether the substance is packaged in a manner
5    normally used for the illegal distribution of controlled
6    substances;
7        (d) whether the distribution or attempted distribution
8    included an exchange of or demand for money or other
9    property as consideration, and whether the amount of the
10    consideration was substantially greater than the
11    reasonable retail market value of the substance.
12    Clause (1) of this subsection (y) shall not apply to a
13noncontrolled substance in its finished dosage form that was
14initially introduced into commerce prior to the initial
15introduction into commerce of a controlled substance in its
16finished dosage form which it may substantially resemble.
17    Nothing in this subsection (y) prohibits the dispensing or
18distributing of noncontrolled substances by persons authorized
19to dispense and distribute controlled substances under this
20Act, provided that such action would be deemed to be carried
21out in good faith under subsection (u) if the substances
22involved were controlled substances.
23    Nothing in this subsection (y) or in this Act prohibits
24the manufacture, preparation, propagation, compounding,
25processing, packaging, advertising or distribution of a drug
26or drugs by any person registered pursuant to Section 510 of



HB4294- 35 -LRB102 21704 SPS 30823 b

1the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
2    (y-1) "Mail-order pharmacy" means a pharmacy that is
3located in a state of the United States that delivers,
4dispenses or distributes, through the United States Postal
5Service or other common carrier, to Illinois residents, any
6substance which requires a prescription.
7    (z) "Manufacture" means the production, preparation,
8propagation, compounding, conversion or processing of a
9controlled substance other than methamphetamine, either
10directly or indirectly, by extraction from substances of
11natural origin, or independently by means of chemical
12synthesis, or by a combination of extraction and chemical
13synthesis, and includes any packaging or repackaging of the
14substance or labeling of its container, except that this term
15does not include:
16        (1) by an ultimate user, the preparation or
17    compounding of a controlled substance for his or her own
18    use;
19        (2) by a practitioner, or his or her authorized agent
20    under his or her supervision, the preparation,
21    compounding, packaging, or labeling of a controlled
22    substance:
23            (a) as an incident to his or her administering or
24        dispensing of a controlled substance in the course of
25        his or her professional practice; or
26            (b) as an incident to lawful research, teaching or



HB4294- 36 -LRB102 21704 SPS 30823 b

1        chemical analysis and not for sale; or
2        (3) the packaging, repackaging, or labeling of drugs
3    only to the extent permitted under the Illinois Drug Reuse
4    Opportunity Program Act.
5    (z-1) (Blank).
6    (z-5) "Medication shopping" means the conduct prohibited
7under subsection (a) of Section 314.5 of this Act.
8    (z-10) "Mid-level practitioner" means (i) a physician
9assistant who has been delegated authority to prescribe
10through a written delegation of authority by a physician
11licensed to practice medicine in all of its branches, in
12accordance with Section 7.5 of the Physician Assistant
13Practice Act of 1987, (ii) an advanced practice registered
14nurse who has been delegated authority to prescribe through a
15written delegation of authority by a physician licensed to
16practice medicine in all of its branches or by a podiatric
17physician, in accordance with Section 65-40 of the Nurse
18Practice Act, (iii) an advanced practice registered nurse
19certified as a nurse practitioner, nurse midwife, or clinical
20nurse specialist who has been granted authority to prescribe
21by a hospital affiliate in accordance with Section 65-45 of
22the Nurse Practice Act, (iv) an animal euthanasia agency, or
23(v) a prescribing psychologist.
24    (aa) "Narcotic drug" means any of the following, whether
25produced directly or indirectly by extraction from substances
26of vegetable origin, or independently by means of chemical



HB4294- 37 -LRB102 21704 SPS 30823 b

1synthesis, or by a combination of extraction and chemical
3        (1) opium, opiates, derivatives of opium and opiates,
4    including their isomers, esters, ethers, salts, and salts
5    of isomers, esters, and ethers, whenever the existence of
6    such isomers, esters, ethers, and salts is possible within
7    the specific chemical designation; however the term
8    "narcotic drug" does not include the isoquinoline
9    alkaloids of opium;
10        (2) (blank);
11        (3) opium poppy and poppy straw;
12        (4) coca leaves, except coca leaves and extracts of
13    coca leaves from which substantially all of the cocaine
14    and ecgonine, and their isomers, derivatives and salts,
15    have been removed;
16        (5) cocaine, its salts, optical and geometric isomers,
17    and salts of isomers;
18        (6) ecgonine, its derivatives, their salts, isomers,
19    and salts of isomers;
20        (7) any compound, mixture, or preparation which
21    contains any quantity of any of the substances referred to
22    in subparagraphs (1) through (6).
23    (bb) "Nurse" means a registered nurse licensed under the
24Nurse Practice Act.
25    (cc) (Blank).
26    (dd) "Opiate" means any substance having an addiction



HB4294- 38 -LRB102 21704 SPS 30823 b

1forming or addiction sustaining liability similar to morphine
2or being capable of conversion into a drug having addiction
3forming or addiction sustaining liability.
4    (ee) "Opium poppy" means the plant of the species Papaver
5somniferum L., except its seeds.
6    (ee-5) "Oral dosage" means a tablet, capsule, elixir, or
7solution or other liquid form of medication intended for
8administration by mouth, but the term does not include a form
9of medication intended for buccal, sublingual, or transmucosal
11    (ff) "Parole and Pardon Board" means the Parole and Pardon
12Board of the State of Illinois or its successor agency.
13    (gg) "Person" means any individual, corporation,
14mail-order pharmacy, government or governmental subdivision or
15agency, business trust, estate, trust, partnership or
16association, or any other entity.
17    (hh) "Pharmacist" means any person who holds a license or
18certificate of registration as a registered pharmacist, a
19local registered pharmacist or a registered assistant
20pharmacist under the Pharmacy Practice Act.
21    (ii) "Pharmacy" means any store, ship or other place in
22which pharmacy is authorized to be practiced under the
23Pharmacy Practice Act.
24    (ii-5) "Pharmacy shopping" means the conduct prohibited
25under subsection (b) of Section 314.5 of this Act.
26    (ii-10) "Physician" (except when the context otherwise



HB4294- 39 -LRB102 21704 SPS 30823 b

1requires) means a person licensed to practice medicine in all
2of its branches.
3    (jj) "Poppy straw" means all parts, except the seeds, of
4the opium poppy, after mowing.
5    (kk) "Practitioner" means a physician licensed to practice
6medicine in all its branches, dentist, optometrist, podiatric
7physician, naturopathic physician, veterinarian, scientific
8investigator, pharmacist, physician assistant, advanced
9practice registered nurse, licensed practical nurse,
10registered nurse, emergency medical services personnel,
11hospital, laboratory, or pharmacy, or other person licensed,
12registered, or otherwise lawfully permitted by the United
13States or this State to distribute, dispense, conduct research
14with respect to, administer or use in teaching or chemical
15analysis, a controlled substance in the course of professional
16practice or research.
17    (ll) "Pre-printed prescription" means a written
18prescription upon which the designated drug has been indicated
19prior to the time of issuance; the term does not mean a written
20prescription that is individually generated by machine or
21computer in the prescriber's office.
22    (mm) "Prescriber" means a physician licensed to practice
23medicine in all its branches, dentist, optometrist,
24prescribing psychologist licensed under Section 4.2 of the
25Clinical Psychologist Licensing Act with prescriptive
26authority delegated under Section 4.3 of the Clinical



HB4294- 40 -LRB102 21704 SPS 30823 b

1Psychologist Licensing Act, podiatric physician, naturopathic
2physician, or veterinarian who issues a prescription, a
3physician assistant who issues a prescription for a controlled
4substance in accordance with Section 303.05, a written
5delegation, and a written collaborative agreement required
6under Section 7.5 of the Physician Assistant Practice Act of
71987, an advanced practice registered nurse with prescriptive
8authority delegated under Section 65-40 of the Nurse Practice
9Act and in accordance with Section 303.05, a written
10delegation, and a written collaborative agreement under
11Section 65-35 of the Nurse Practice Act, an advanced practice
12registered nurse certified as a nurse practitioner, nurse
13midwife, or clinical nurse specialist who has been granted
14authority to prescribe by a hospital affiliate in accordance
15with Section 65-45 of the Nurse Practice Act and in accordance
16with Section 303.05, or an advanced practice registered nurse
17certified as a nurse practitioner, nurse midwife, or clinical
18nurse specialist who has full practice authority pursuant to
19Section 65-43 of the Nurse Practice Act.
20    (nn) "Prescription" means a written, facsimile, or oral
21order, or an electronic order that complies with applicable
22federal requirements, of a physician licensed to practice
23medicine in all its branches, dentist, podiatric physician,
24naturopathic physician, or veterinarian for any controlled
25substance, of an optometrist in accordance with Section 15.1
26of the Illinois Optometric Practice Act of 1987, of a



HB4294- 41 -LRB102 21704 SPS 30823 b

1prescribing psychologist licensed under Section 4.2 of the
2Clinical Psychologist Licensing Act with prescriptive
3authority delegated under Section 4.3 of the Clinical
4Psychologist Licensing Act, of a physician assistant for a
5controlled substance in accordance with Section 303.05, a
6written delegation, and a written collaborative agreement
7required under Section 7.5 of the Physician Assistant Practice
8Act of 1987, of an advanced practice registered nurse with
9prescriptive authority delegated under Section 65-40 of the
10Nurse Practice Act who issues a prescription for a controlled
11substance in accordance with Section 303.05, a written
12delegation, and a written collaborative agreement under
13Section 65-35 of the Nurse Practice Act, of an advanced
14practice registered nurse certified as a nurse practitioner,
15nurse midwife, or clinical nurse specialist who has been
16granted authority to prescribe by a hospital affiliate in
17accordance with Section 65-45 of the Nurse Practice Act and in
18accordance with Section 303.05 when required by law, or of an
19advanced practice registered nurse certified as a nurse
20practitioner, nurse midwife, or clinical nurse specialist who
21has full practice authority pursuant to Section 65-43 of the
22Nurse Practice Act.
23    (nn-5) "Prescription Information Library" (PIL) means an
24electronic library that contains reported controlled substance
26    (nn-10) "Prescription Monitoring Program" (PMP) means the



HB4294- 42 -LRB102 21704 SPS 30823 b

1entity that collects, tracks, and stores reported data on
2controlled substances and select drugs pursuant to Section
4    (oo) "Production" or "produce" means manufacture,
5planting, cultivating, growing, or harvesting of a controlled
6substance other than methamphetamine.
7    (pp) "Registrant" means every person who is required to
8register under Section 302 of this Act.
9    (qq) "Registry number" means the number assigned to each
10person authorized to handle controlled substances under the
11laws of the United States and of this State.
12    (qq-5) "Secretary" means, as the context requires, either
13the Secretary of the Department or the Secretary of the
14Department of Financial and Professional Regulation, and the
15Secretary's designated agents.
16    (rr) "State" includes the State of Illinois and any state,
17district, commonwealth, territory, insular possession thereof,
18and any area subject to the legal authority of the United
19States of America.
20    (rr-5) "Stimulant" means any drug that (i) causes an
21overall excitation of central nervous system functions, (ii)
22causes impaired consciousness and awareness, and (iii) can be
23habit-forming or lead to a substance abuse problem, including,
24but not limited to, amphetamines and their analogs,
25methylphenidate and its analogs, cocaine, and phencyclidine
26and its analogs.



HB4294- 43 -LRB102 21704 SPS 30823 b

1    (rr-10) "Synthetic drug" includes, but is not limited to,
2any synthetic cannabinoids or piperazines or any synthetic
3cathinones as provided for in Schedule I.
4    (ss) "Ultimate user" means a person who lawfully possesses
5a controlled substance for his or her own use or for the use of
6a member of his or her household or for administering to an
7animal owned by him or her or by a member of his or her
9(Source: P.A. 101-666, eff. 1-1-22; 102-389, eff. 1-1-22;
10l02-538, eff. 8-20-21; revised 9-22-21.)
11    Section 999. Effective date. This Act takes effect upon
12becoming law.